These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1345741)

  • 21. IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier.
    Niemelä J; Ifergan I; Yegutkin GG; Jalkanen S; Prat A; Airas L
    Eur J Immunol; 2008 Oct; 38(10):2718-26. PubMed ID: 18825744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
    Barkhof F; van Walderveen M
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The pathogenesis of multiple sclerosis].
    Kesselring J
    Schweiz Med Wochenschr; 1990 Jul; 120(30):1083-90. PubMed ID: 2203139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood-brain barrier imaging and therapeutic potentials.
    Rebeles F; Fink J; Anzai Y; Maravilla KR
    Top Magn Reson Imaging; 2006 Apr; 17(2):107-16. PubMed ID: 17198226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain-immune connection: immuno-regulatory properties of CNS-resident cells.
    Becher B; Prat A; Antel JP
    Glia; 2000 Feb; 29(4):293-304. PubMed ID: 10652440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of interferon-beta treatment on the blood-brain barrier.
    Kraus J; Oschmann P
    Drug Discov Today; 2006 Aug; 11(15-16):755-62. PubMed ID: 16846804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis.
    Vos CM; Geurts JJ; Montagne L; van Haastert ES; Bö L; van der Valk P; Barkhof F; de Vries HE
    Neurobiol Dis; 2005 Dec; 20(3):953-60. PubMed ID: 16039866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood-brain barrier disruption in multiple sclerosis.
    Minagar A; Alexander JS
    Mult Scler; 2003 Dec; 9(6):540-9. PubMed ID: 14664465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A dynamic view of the blood-brain barrier in active multiple sclerosis lesions.
    Lassmann H
    Ann Neurol; 2011 Jul; 70(1):1-2. PubMed ID: 21710628
    [No Abstract]   [Full Text] [Related]  

  • 30. [Implication of the blood-brain barrier in neurological diseases: part II].
    Weiss N; Miller F; Cazaubon S; Couraud PO
    Rev Neurol (Paris); 2009 Dec; 165(12):1010-22. PubMed ID: 19487004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple sclerosis as a vascular disease.
    Minagar A; Jy W; Jimenez JJ; Alexander JS
    Neurol Res; 2006 Apr; 28(3):230-5. PubMed ID: 16687046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The blood-brain barrier in multiple sclerosis: microRNAs as key regulators.
    Kamphuis WW; Derada Troletti C; Reijerkerk A; Romero IA; de Vries HE
    CNS Neurol Disord Drug Targets; 2015; 14(2):157-67. PubMed ID: 25613507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hyperhomocysteinemia and endothelial dysfunction in patients with cerebral vascular and autoimmune diseases].
    Dubchenko EA; Ivanov AV; Boiko AN; Spirina NN; Gusev EI; Kubatiev AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(11):133-138. PubMed ID: 31851185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier.
    Spencer JI; Bell JS; DeLuca GC
    J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):42-52. PubMed ID: 28860328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multiple sclerosis and endothelial dysfunction (a review)].
    Spirina NN; Spirin NN; Fadeeva OA; Shipova EG; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(10 Pt 2):32-42. PubMed ID: 24416810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis.
    Claudio L; Raine CS; Brosnan CF
    Acta Neuropathol; 1995; 90(3):228-38. PubMed ID: 8525795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased adhesion of CD4+ and CD14+ mononuclear cells to cultured multiple sclerosis brain endothelial cells.
    Dufour A; Corsini E; Giombini S; Nespolo A; Milanese C; Salmaggi A
    J Neurol; 1996 Sep; 243(9):666-7. PubMed ID: 8892072
    [No Abstract]   [Full Text] [Related]  

  • 38. Blood brain barrier compromise with endothelial inflammation may lead to autoimmune loss of myelin during multiple sclerosis.
    Simka M
    Curr Neurovasc Res; 2009 May; 6(2):132-9. PubMed ID: 19442163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plaques, T cells and beyond: report on an international meeting on the immunological basis of multiple sclerosis held at the University of Chieti, Italy.
    Muraro PA; Martin R; Lassmann H; Gambi D
    J Neuroimmunol; 1999 May; 96(2):251-4. PubMed ID: 10337925
    [No Abstract]   [Full Text] [Related]  

  • 40. Search for autoantibodies to endothelial and smooth muscle cells in patients with multiple sclerosis.
    Tsukada N; Behan WM; Behan PO
    Acta Neuropathol; 1985; 66(2):134-9. PubMed ID: 3874512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.